Brussels, 18/06/2009 (Agence Europe) - The European Commission decided on Thursday 18 June not to raise any objections to the financial support of €33 million granted by France to Carmat's R&D programme. The lead company, Carmat S.A.S., backed up by four industrial partners and a large number of SMEs acting as subcontractors, will have the task of designing and developing an artificial heart that is fully implantable, together with the associated electrical supply and telediagnostic...